Citadel Advisors’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History

Citadel Advisors’s Portfolio VHAQ.WS Stock Details VHAQ.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,652	Closed	-$214	–	15446
2023 Q2	$214	Buy	+10,652	New	+$284	﹤0.01%	14186
2022 Q4	–	Sell	-16,908	Closed	-$2K	–	15701
2022 Q3	$2K	Buy	16,908 +1,401	+9%	+$99	﹤0.01%	12433
2022 Q2	$1K	Sell	15,507 -499,911	-97%	-$38K	﹤0.01%	12736
2022 Q1	$40K	Buy	515,418 +187	+0%	+$24	﹤0.01%	12944
2021 Q4	$111K	Sell	515,231 -346	-0.1%	-$94	﹤0.01%	12615
2021 Q3	$129K	Buy	515,577 +390	+0.1%	+$119	﹤0.01%	12562
2021 Q2	$181K	Sell	515,187 -6,607	-1%	-$2.38K	﹤0.01%	12280
2021 Q1	$198K	Buy	+521,794	New	+$280K	﹤0.01%	11717

Other funds holding VHAQ.WS

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Citadel Advisors's VHAQ.WS Position: Q3 2023 in Review

Citadel Advisors sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q3 2023, closing a stake of 10,652 shares — an estimated $214 sold.

Citadel Advisors first reported a position in VHAQ.WS in Q1 2021 and held it in 8 quarters. The position peaked at $198K in Q1 2021. 32 funds tracked by Wall St. Rank hold VHAQ.WS as of Q3 2023.

Citadel Advisors reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 10,652 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q3 2023, an estimated $214.
Citadel Advisors first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q1 2021 and held it in 8 quarters.
Citadel Advisors's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $198K in Q1 2021.
32 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.